Neimeth International Pharmaceuticals Plc is seeking shareholder approval for a N1.98 billion capital restructuring that could significantly reshape its balance sheet and future dividend capacity.
The move follows a February 5, 2026, order of the Federal High Court directing the company to convene a Court-Ordered Meeting (COM) to consider a Scheme of Arrangement. The virtual meeting is scheduled for March 31, 2026.
While the proposal is largely technical, its implications are strategic.
The company plans to reduce its share premium account from N2.38 billion to N390.02 million. The difference, N1.99 billion, will be transferred to its revenue reserve.
This is an internal equity adjustment. It does not involve new shares, cash payments or changes to shareholders’ ownership stakes. Instead, it reclassifies funds already sitting within shareholders’ equity.
Share premium typically represents the excess paid by investors above the nominal value of shares during previous capital raises. Though it forms part of equity, it is generally not available for dividend distribution under Nigerian corporate law.
Revenue reserve, by contrast, reflects accumulated profits or losses. If a company records sustained losses over time, the reserve becomes negative, creating a retained deficit.
Read also: Neimeth’s earnings rebound resets a volatile five-year cycle
The timing is not accidental. Neimeth recently reported a decisive return to profitability, posting a Profit After Tax (PAT) of N982.1 million for the 2025 financial year, reversing a N885.3 million loss in 2024.
Despite this profit, the company’s ability to pay dividends remains legally “trapped” by an accumulated loss (retained deficit) of approximately N1.88 billion (as of Dec 2025). Under the Companies and Allied Matters Act (CAMA), a company cannot pay dividends until its accumulated losses are wiped out.
By transferring N1.99 billion from share premium to revenue reserve, Neimeth is effectively offsetting accumulated losses. The objective is to eliminate or significantly reduce its retained deficit and restore distributable reserves.
In practical terms, the move positions the company to pay dividends in the future, subject to profitability and regulatory requirements.
This restructuring does not create new earnings or improve cash flow. It is a balance sheet reorganisation designed to improve financial flexibility and clean up historical deficits.
For shareholders, the immediate impact is neutral. There is no dilution and no direct payout linked to the transaction.
However, the long-term implications could be meaningful. A company with a cleaned-up reserve account is structurally better positioned to declare dividends once it generates profits. Without such a restructuring, retained losses could continue to constrain capital distribution.
The move may also improve how the company’s financial position is perceived by lenders and institutional investors. Large accumulated losses can weigh on valuations and signal financial strain. Resetting the reserve enhances the presentation of shareholders’ funds and may strengthen confidence in the company’s capital structure.
Across Nigeria’s listed space, similar reserve reorganisations have been used by companies emerging from periods of volatility to stabilise their books and rebuild investor trust.
The restructuring is structured as a Scheme of Arrangement, which requires both shareholder consent and court sanction.
At the March 31 Court-Ordered Meeting, at least 75 percent in value of the shares represented and voting must approve the resolution for it to pass. This statutory majority threshold ensures broad investor support before implementation.
The meeting will be conducted virtually, in line with the Business Facilitation Act 2022, which allows fully electronic shareholder meetings. Shareholders must complete e-accreditation through the Meristem Registrars portal, including One-Time Password verification.
Only investors whose names appear on the register as of March 23, 2026, will be eligible to vote. Questions on the scheme must be submitted by March 24, and proxy forms must be lodged at least 48 hours before the meeting.
Read also: Neimeth’s earnings up 9% despite rising cost pressures
If shareholders vote in favour, Neimeth will return to the Federal High Court for final sanction. Once the court endorses the scheme, it becomes legally binding, and the revised capital structure can be implemented.
The restructuring does not guarantee improved performance. It does not automatically translate into dividends. What it does is remove a structural constraint and reset the company’s equity accounts.
For Neimeth, the proposal represents a financial clean-up exercise aimed at strengthening its foundation. For investors, the key question is whether this reset will be followed by sustained profitability that can translate into real returns.
The March 31 vote will determine whether the company gets the balance sheet it needs for that next phase.